Piero Custodio-Sanchez
Overview
Explore the profile of Piero Custodio-Sanchez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
31
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lopez-Rojas L, Paredes Paucar C, Rojas De La Cuba P, Yabar Galindo W, Martos Salcedo J, Custodio-Sanchez P
Arch Peru Cardiol Cir Cardiovasc
. 2024 Jul;
5(2):e368.
PMID: 39015188
No abstract available.
2.
Custodio-Sanchez P, Miranda D, Murillo L
Arch Peru Cardiol Cir Cardiovasc
. 2024 Apr;
1(2):67-74.
PMID: 38572337
Purpose: To compare the number of admissions, clinical features and therapeutic outcomes of patients treated for acute ST-segment elevation myocardial infarction (STEMI), before and after the COVID-19 pandemic state of...
3.
Custodio-Sanchez P, Miranda-Noe D, Lopez-Rojas L, Paredes Paucar C, Yabar Galindo W, Rojas De La Cuba P, et al.
Arch Peru Cardiol Cir Cardiovasc
. 2024 Feb;
4(4):164-183.
PMID: 38298415
ST-segment elevation myocardial infarction (STEMI) is a clinical entity whose adequate treatment will depend on its prompt recognition, accurate diagnosis, and management in reperfusion networks. The first contact with these...
4.
Chacon-Diaz M, Rodriguez Olivares R, Miranda Noe D, Custodio-Sanchez P, Montesinos Cardenas A, Yabar Galindo G, et al.
Arch Peru Cardiol Cir Cardiovasc
. 2023 Sep;
2(2):86-95.
PMID: 37727802
Background: ST-segment elevation myocardial infarction (STEMI), is an important cause of morbidity and mortality worldwide, and myocardial reperfusion, when adequate, reduces the complications of this entity. The aim of the...
5.
Carrion Arcela J, Custodio-Sanchez P, Coca Caycho T
Arch Peru Cardiol Cir Cardiovasc
. 2023 Sep;
2(3):159-166.
PMID: 37727520
Objective: To evaluate the impact of the COVID-19 pandemic on the ST-Elevation myocardial infarction (STEMI) management in a reference center of northern Peru. Methods: Observational, analytical, retrospective cohort-type study, derivated...
6.
Carrion-Arcela J, Custodio-Sanchez P, Rodriguez-Urteaga Z, Rios-Vasquez C
Arch Peru Cardiol Cir Cardiovasc
. 2023 Sep;
2(1):63-67.
PMID: 37727261
Rupture of a Valsalva aneurysm in the adult is extremely rare and is often complicated by acute heart failure. We present the case of a 39-year-old patient with a non-coronary...
7.
Chacon-Diaz M, Hernandez-Vasquez A, Custodio-Sanchez P
Arch Peru Cardiol Cir Cardiovasc
. 2023 Jun;
3(2):53-59.
PMID: 37351306
Objectives: To determine one-year survival and factors associated with mortality in patients with ST-segment elevation myocardial infarction in Peru. Methods: An analysis was made of the cohort of patients included...
8.
Paredes-Paucar C, Custodio-Sanchez P, Chacon-Diaz M
Arch Peru Cardiol Cir Cardiovasc
. 2023 Jun;
3(4):196-203.
PMID: 37351015
Objective: To determine the clinical factors associated to no-reflow after percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction (STEMI) in Peru. Materials And Methods: Case - control...
9.
Chacon-Diaz M, Custodio-Sanchez P, Rojas De La Cuba P, Yabar-Galindo G, Rodriguez-Olivares R, Miranda-Noe D, et al.
BMC Cardiovasc Disord
. 2022 Jun;
22(1):296.
PMID: 35768779
Objective: The primary percutaneous coronary intervention (PPCI) is the preferred reperfusion strategy for ST-segment elevation myocardial infarction (STEMI). The pharmacoinvasive strategy (PIs) is a reasonable alternative when prompt PPCI is...
10.
Sosa Liprandi A, Zaidel E, Lopez Santi R, Araujo J, Banos Gonzalez M, Busso J, et al.
Vaccines (Basel)
. 2021 Feb;
9(2).
PMID: 33557082
Background: Influenza vaccination (IV) and Pneumococcus vaccination (PV) are recommended for patients with cardiometabolic diseases. This study aimed to evaluate the immunization rate of ambulatory cardiometabolic patients during the COVID-19...